ArticleMedical science monitor : international medical journal of experimental and clinical research2026
Association of miR-133a With Microalbuminuria in Patients With Resistant Arterial Hypertension and Chronic Kidney Disease.
Article in Medical science monitor : international medical journal of experimental and clinical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- MicroRNA expression profile associated with coronary heart disease in patients with resistant arterial hypertension.Frontiers in molecular biosciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND MicroRNAs (miRNAs) are important post-transcriptional regulators of gene expression and have emerged as potential biomarkers of cardiovascular and renal diseases. Resistant arterial hypertension (RAH) is frequently associated with chronic kidney disease (CKD) and microalbuminuria, reflecting early microvascular damage. However, the relationship between microRNA expression and microalbuminuria in patients with RAH remains insufficiently researched. This study aimed to evaluate the expression of selected miRNAs in patients with RAH, with and without CKD, and to assess their association with urinary albumin excretion. MATERIAL AND METHODS This cross-sectional study included 115 patients with RAH, of whom 42 (36.5%) had coexisting CKD. The expression levels of 11 selected miRNAs were assessed in peripheral blood mononuclear cells using quantitative real-time polymerase chain reaction. Urinary albumin-to-creatinine ratio (UACR) was used to assess albuminuria. Correlations between microRNA expression and UACR were analyzed using Spearman's rank correlation. RESULTS In patients with RAH and microalbuminuria, a statistically significant positive correlation was observed between hsa-miR-133a expression and UACR (Spearman's r=0.38, P=0.024, n=35). No significant correlations were found between urinary albumin excretion and other analyzed microRNAs or in patients without microalbuminuria. CONCLUSIONS Expression of hsa-miR-133a was associated with urinary albumin excretion in patients with RAH and microalbuminuria. The findings suggest that hsa-miR-133a may be a potential noninvasive biomarker of microalbuminuria and early renal microvascular injury in a high-risk hypertensive population; however, further longitudinal studies are required to clarify the prognostic value and clinical utility of miR-133a in this patient population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.